Regeneron Pharmaceuticals | REGN - Receita De Vendas

Preço das Ações
745.77
Mudança Diária
-0.84 -0.11%
Mensal
-6.02%
Anual
11.83%
Q1 Previsão
723.25




Vendas Alterar Data
AbbVie USD 16.62B 840M 2025-12
Agenus USD 24.07M 2.77M 2025-03
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
J&J USD 24.6B 610M 2025-12
Kyowa Hakko Kirin JPY 147.38B 28.58B 2025-12
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.91B 144M 2025-09
Novartis USD 14.36B 478M 2025-09
Pfizer USD 17.58B 880M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 12.2B 3.19B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12